Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1383.00
6.75 (0.49%) Cipla - Quaterly Results
Date: 14-05-2026
A decrease in the sales to Rs. 42099.80 millions was observed for the quarter ended March 2026. The sales stood at Rs. 47978.90 millions during the similar quarter previous year.A big decline of -74.11% was reported for the quarter ended March 2026 to Rs. 3846.40 millions from Rs. 14854.00 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 7783.30 millions from 16120.80 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 42099.80 | 47978.90 | -12.25 | 189799.50 | 190448.50 | -0.34 | 189799.50 | 190448.50 | -0.34 |
| Other Income | 1802.20 | 2933.70 | -38.57 | 11226.50 | 9847.20 | 14.01 | 11226.50 | 9847.20 | 14.01 |
| PBIDT | 7783.30 | 16120.80 | -51.72 | 55890.40 | 67631.60 | -17.36 | 55890.40 | 67631.60 | -17.36 |
| Interest | 67.40 | 34.90 | 93.12 | 193.00 | 151.10 | 27.73 | 193.00 | 151.10 | 27.73 |
| PBDT | 7715.90 | 19032.50 | -59.46 | 53253.70 | 70427.10 | -24.38 | 53253.70 | 70427.10 | -24.38 |
| Depreciation | 2491.10 | 1477.00 | 68.66 | 6894.30 | 5738.90 | 20.13 | 6894.30 | 5738.90 | 20.13 |
| PBT | 5224.80 | 17555.50 | -70.24 | 46359.40 | 64688.20 | -28.33 | 46359.40 | 64688.20 | -28.33 |
| TAX | 1378.40 | 2701.50 | -48.98 | 11207.60 | 13111.70 | -14.52 | 11207.60 | 13111.70 | -14.52 |
| Deferred Tax | 180.70 | -625.60 | -128.88 | 188.60 | -491.50 | -138.37 | 188.60 | -491.50 | -138.37 |
| PAT | 3846.40 | 14854.00 | -74.11 | 35151.80 | 51576.50 | -31.85 | 35151.80 | 51576.50 | -31.85 |
| Equity | 1615.60 | 1615.20 | 0.02 | 1615.60 | 1615.20 | 0.02 | 1615.60 | 1615.20 | 0.02 |
| PBIDTM(%) | 18.49 | 33.60 | -44.98 | 29.45 | 35.51 | -17.08 | 29.45 | 35.51 | -17.08 |